Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants

View source ↗

Summary

A completed clinical trial evaluating the risk of severe uterine bleeding associated with exposure to direct oral anticoagulants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Uterine Hemorrhage | Status: COMPLETED